Table 2 Median survival based on Eag and HERG immunoreactivity and other prognostic markers.
From: The Eag potassium channel as a new prognostic marker in ovarian cancer
| Â | Median survival, Months(IQR) | P (log rank) |
|---|---|---|
Eag staining | Â | Â |
Low/Intermediate | 24.1 (18.9-29.2) | Â |
High | 13.8 (7.2-20.3) | 0.016 |
HERG staining | Â | Â |
Low/Intermediate | 22.4 (14.1-30.6) | Â |
High | 16.4 (9.7-23.0) | 0.586 |
Stage | Â | Â |
1 | 137.6 (48.8-226.3) | Â |
2 | 28.4 (4.8-51.9) | Â |
3 | 13.0 (9.0-16.9) | Â |
4 | 7.3 (0-15.2) | < 0.001 |
Grade | Â | Â |
G1 | 28.9 (17.2-40.5) | Â |
G2 | 33.1 (16.4-49.7) | Â |
G3 | 16.0 (13.0-18.9) | 0.001 |
Residual disease | Â | Â |
No macroscopic disease (Optimal debulking) | 65.2 (37.5-92.8) | Â |
Macroscopic disease | 10.7 (7.6-13.7) | < 0.001 |
Histological type | Â | Â |
Serous | 17.3 (12.6-21.9) | Â |
Mucinous | 30.7 (0-64.7) | < 0.001 |
Endometriod | 26.6 (5.3-47.8) | Â |
Clear cell | 155 (89.7-222) | Â |
Undifferentiated | 13.3(5.3-21.2) | Â |
Adjuvant Chemotherapy | Â | Â |
Yes | 20.3 (15.4-25.1) | Â |
No | 18.8 (0.6-36.9) | 0.04 |